AdvaMed®’s Medtech POV blog features all the latest developments, perspectives, and resources by and for the medical technology community.
AdvaMed’s 2025 Cybersecurity Summit gathered industry and regulatory leaders to explore today’s cyber threats and align on solutions. Key themes included FDA expectations, hospital security realities, and the cultural shifts…
Despite the prevalence of diabetes, millions of people who could benefit from the latest medtech management tools are unserved or underserved. Patients who do receive a diagnosis and access to…
Imagine walking just 10 yards from your front door to the mailbox and becoming so winded, you feel like you might faint. Or imagine your heart beating so chaotically that…
As patient advocates, we’ve witnessed countless stories of hope deferred and lives put on hold while Medicare beneficiaries wait several years for access to breakthrough medical technologies that the FDA…
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
AdvaMed was honored to address delegates at the 12th Asia-Pacific Economic Cooperation (APEC) Business Ethics for SMEs Forum held in Seoul, Korea, on September 8-9, 2025. AdvaMed galvanized delegates from…
Bobby Patrick, AdvaMed’s SVP of Government & State Affairs and Alliance Development, on why #MTC25 is the can’t-miss moment to see the power of coalitions in action — where patients,…
Zach Rothstein, Executive Director of AdvaMedDx, on why this year’s diagnostics programming comes at an inflection point for IVD leaders — with regulatory modernization, reimbursement reform, and breakthrough technologies creating…
Christopher L. White, Esq., AdvaMed’s General Counsel & Chief Policy Officer, on why this year’s legal, compliance & regulatory programming is mission-critical as medtech leaders navigate uncertainty, shifting enforcement priorities,…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 202-434-7242
DeChane Dorsey, Executive Director of AdvaMed Accel and a leading voice for early-stage innovation, to explore why this year’s programming is especially critical for small companies and entrepreneurs.
Join over 500 medical technology companies as a member of one of the most effective trade associations in Washington, D.C.